NCT01206764 A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma. Status COMPLETED Phase PHASE4
NCT01204203 Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) Status COMPLETED Phase PHASE2
NCT01202903 Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy Status COMPLETED Phase PHASE3
NCT01202188 A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT01201356 Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT01200589 Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy Status TERMINATED Phase PHASE3
NCT01197300 1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids Status COMPLETED Phase PHASE3
NCT01197287 Safety, Tolerability and Pharmacokinetics of QAK423A in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) Patients Status COMPLETED Phase PHASE1
NCT01195376 A Study of BEZ235 in Adult Japanese Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01193101 Efficacy and Safety of LCZ696 Compared to Placebo in Patients With Essential Hypertension Status COMPLETED Phase PHASE2
NCT01185821 Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT01184872 Study to Compare Efficacy and Safety of Daptomycin in Elderly Patients With Complicated Skin and Soft Tissue Infections Status COMPLETED Phase PHASE3
NCT01182168 Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies Status COMPLETED Phase PHASE1
NCT01179737 Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH) Status TERMINATED Phase PHASE2
NCT01176032 ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling Status COMPLETED Phase PHASE4
NCT01173731 Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias Status COMPLETED Phase PHASE2
NCT01172548 Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST) Status COMPLETED Phase PHASE2